Cornelia B. Landersdorfer

Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens

Ana Maria Sandri, Cornelia B. Landersdorfer, Jovan Jacob et al. · Clinical Infectious Diseases · 2013 · 428 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection models

Cornelia B. Landersdorfer, Jiping Wang, Veronika Wirth et al. · Journal of Antimicrobial Chemotherapy · 2017 · 138 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Development of a New Pre- and Post-Processing Tool (SADAPT-TRAN) for Nonlinear Mixed-Effects Modeling in S-ADAPT

Jürgen B. Bulitta, Beom Soo Shin, Cornelia B. Landersdorfer · The AAPS Journal · 2011 · 119 citations

Pharmacy, Psychology, Experimental Design +10

Evaluation by Monte Carlo Simulation of the Pharmacokinetics of Two Doses of Meropenem Administered Intermittently or as a Continuous Infusion in Healthy Volunteers

Wolfgang A. Krueger, Jürgen B. Bulitta, Martina Kinzig‐Schippers et al. · Antimicrobial Agents and Chemotherapy · 2005 · 104 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

iAMPCN: a deep-learning approach for identifying antimicrobial peptides and their functional activities

Jing Xu, Fuyi Li, Chen Li et al. · Briefings in Bioinformatics · 2023 · 104 citations · Full text

Life Sciences, Biochemistry, Bioinformatics +11